Machine Learning Scientist II/Sr (Omics)
Axsome Therapeutics Inc$152,000 - $215,000/year
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Junior (1 to 2 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Artificial Intelligence, Biotechnology, Research, AI & Machine LearningIndustries
Requirements
Candidates must hold a Bachelor's degree in Computer Science, Computer Engineering, Mathematics, Physics, or a related technical field, and possess a PhD with 2 years of research experience or equivalent experience with 4 years of research or industry experience in Deep Learning, Artificial Intelligence, or other relevant fields. They should have a strong publication record in top-tier AI conferences or journals such as NeurIPS, ICML, or ICLR, and be proficient in Python with expertise in at least one major deep learning framework like PyTorch, TensorFlow, or JAX.
Responsibilities
As a Machine Learning Research Scientist, you will train and scale innovative multimodal AI models on large, diverse biological datasets across distributed GPU clusters, innovate on cutting-edge machine learning algorithms to enhance model performance and biological understanding, design and conduct experiments to validate model capabilities across various biological phenomena, solve challenging AI research problems at scale, and span various advanced generative AI architectures including transformers, diffusion models, and autoencoders to push the boundaries of biological AI.
Skills
Python
PyTorch
TensorFlow
JAX
Deep Learning
Machine Learning
Transformers
Diffusion Models
Autoencoders
Generative AI
Biological Data
Distributed Computing
GPU Clusters
Output Biosciences
Develops preventative therapies for chronic diseases
About Output Biosciences
Output Biosciences focuses on developing preventative therapies aimed at extending human healthspan by addressing chronic diseases such as diabetes and heart disease. The company combines biotechnology with artificial intelligence to create therapies that can be discovered and manufactured more quickly and safely than traditional methods. This allows them to bring new treatments to market in just a few months, which is much faster than the usual drug development process. Their main clients include healthcare providers, pharmaceutical companies, and research institutions seeking effective solutions for chronic disease management. Output Biosciences differentiates itself by leveraging computational biology to streamline therapy development and commercialization, generating revenue through partnerships and licensing. The goal of Output Biosciences is to fundamentally change healthcare by preventing chronic diseases before they occur.
New York City, New YorkHeadquarters
2020Year Founded
$125KTotal Funding
PRE_SEEDCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1-10Employees